Cleavage of the Anaplastic Lymphoma Kinase in Neuroblastoma
Neuroblastoma, a tumor of the sympathetic nervous system, is responsible for 15% of all childhood cancer deaths. Genetic aberrations in the anaplastic lymphoma kinase (ALK) receptor tyrosine kinase have been implicated as a contributing factor in neuroblastoma pathogenesis. Of all neuroblastomas, h...
Main Author: | Yeung, Caleb Matthew |
---|---|
Format: | Others |
Language: | en |
Published: |
Harvard University
2016
|
Online Access: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:27007739 |
Similar Items
-
Amino acid residues critical for anaplastic lymphoma kinase receptor cleavage
by: Shetty, Kunal
Published: (2016) -
Mechanistic Implications and Characterization of Anaplastic Lymphoma Kinase (ALK) mutations in Neuroblastoma
by: Chand, Damini
Published: (2015) -
Therapeutic Targeting of the Anaplastic Lymphoma Kinase (ALK) in Neuroblastoma—A Comprehensive Update
by: Annette K. Brenner, et al.
Published: (2021-09-01) -
Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
by: Farina F, et al.
Published: (2014-08-01) -
Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma
by: Tian C, et al.
Published: (2016-09-01)